Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction | MicrobiomeTrials← Back to trialsNCT07880743
Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-11Est. Completion: 2028-11
Enrollment target: 100 participants Locations- Endeavor Health/NorthShore, Skokie, Illinois, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Duke University, Durham, North Carolina, United States
- University of Cincinnati / UC Health Orthopaedics & Sports Medicine, Cincinnati, Ohio, United States
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
- Campbell Clinic, Germantown, Tennessee, United States
Other microbiome trials you might be interested in
Anterior Cruciate Ligament TearAnkle Sprains
BACKGROUND:
Anterior cruciate ligament (ACL) is an important ligamentous structure in the knee joint which contributes …
Cairo, EgyptCompleted Nov 1, 2025
ACL Tears
This research study will evaluate mid-term clinical safety and performance outcomes of the BioBrace® Reinforced Implant …
New Haven, United StatesEst. completion Jun 2030